Drew Wilkins

Drew Wilkins is a Managing Director in Deloitte Consulting LLP’s commercial strategy practice. He has more than 20 years of consulting experience and focuses on commercial strategy and innovative business models for biopharmaceutical and medtech clients. He helps clients solve the strategic challenges associated with growth, innovation and ecosystem disruption. This includes a focus on innovative access models and health equity for commercial life sciences organizations. Drew also leads Deloitte’s efforts related to innovative financing models for advanced and emerging therapies, including cell and gene therapies. His recent work includes designing a novel supplemental risk pool to spread the cost of gene therapies across multiple payers. Drew earned his BS from Vanderbilt University and his MBA from the Tuck School of Business at Dartmouth College. He lives in Annapolis, Maryland with his school-aged children.